JP2017530193A5 - - Google Patents

Download PDF

Info

Publication number
JP2017530193A5
JP2017530193A5 JP2017535616A JP2017535616A JP2017530193A5 JP 2017530193 A5 JP2017530193 A5 JP 2017530193A5 JP 2017535616 A JP2017535616 A JP 2017535616A JP 2017535616 A JP2017535616 A JP 2017535616A JP 2017530193 A5 JP2017530193 A5 JP 2017530193A5
Authority
JP
Japan
Prior art keywords
alkyl
heteroaryl
heterocycloalkyl
aryl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017535616A
Other languages
English (en)
Japanese (ja)
Other versions
JP6615207B2 (ja
JP2017530193A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/051143 external-priority patent/WO2016048861A2/en
Publication of JP2017530193A publication Critical patent/JP2017530193A/ja
Publication of JP2017530193A5 publication Critical patent/JP2017530193A5/ja
Application granted granted Critical
Publication of JP6615207B2 publication Critical patent/JP6615207B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017535616A 2014-09-22 2015-09-21 複素環式化合物及びその使用 Active JP6615207B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462053389P 2014-09-22 2014-09-22
US62/053,389 2014-09-22
PCT/US2015/051143 WO2016048861A2 (en) 2014-09-22 2015-09-21 Heterocyclic compounds and use thereof

Publications (3)

Publication Number Publication Date
JP2017530193A JP2017530193A (ja) 2017-10-12
JP2017530193A5 true JP2017530193A5 (2) 2018-11-01
JP6615207B2 JP6615207B2 (ja) 2019-12-04

Family

ID=55525127

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017535616A Active JP6615207B2 (ja) 2014-09-22 2015-09-21 複素環式化合物及びその使用

Country Status (12)

Country Link
US (2) US9862703B2 (2)
EP (1) EP3197885B1 (2)
JP (1) JP6615207B2 (2)
KR (1) KR102509431B1 (2)
CN (1) CN107207465B (2)
AU (1) AU2015321654B2 (2)
BR (1) BR112017005713B1 (2)
CA (1) CA2962329C (2)
ES (1) ES2849998T3 (2)
RU (1) RU2704008C2 (2)
TW (1) TWI598348B (2)
WO (1) WO2016048861A2 (2)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2756055C2 (ru) * 2017-01-10 2021-09-24 Нэшнл Хелт Рисерч Инститьютс Гетероциклические соединения и их применение
KR20240151869A (ko) * 2017-09-08 2024-10-18 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 Enpp1 저해제 및 암의 치료용의 이의 용도
EP3842435A4 (en) 2018-09-20 2022-05-11 Hanmi Pharm. Co., Ltd. NOVEL SULFONAMIDE DERIVATIVE WITH FUSED PYRIMIDINE FRAMEWORK WITH INHIBITING ACTIVITY ON EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS
JP7777332B2 (ja) * 2019-02-01 2025-11-28 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 免疫応答をモジュレートするenpp1阻害剤および方法
CN111138417B (zh) * 2019-12-18 2021-03-23 浙江工业大学 一种三氮唑修饰的5-氟-2,4-嘧啶二胺类化合物及其应用
CA3228210A1 (en) * 2021-08-02 2023-02-09 National Health Research Institutes Pyrimidine compounds and use thereof
IL320644A (en) * 2022-11-07 2025-07-01 Univ Kyoto Quinazoline derivatives
UY40657A (es) 2023-03-01 2024-09-13 Novartis Ag Derivados de hidroquinazolina para el tratamiento de una enfermedad o un trastorno

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4936700A (2) * 1972-08-16 1974-04-05
ES2150941T3 (es) * 1992-04-03 2000-12-16 Upjohn Co Aminas biciclicas-heterociclicas eficaces farmaceuticamente.
US6156758A (en) * 1999-09-08 2000-12-05 Isis Pharmaceuticals, Inc. Antibacterial quinazoline compounds
EP2043651A2 (en) * 2006-07-05 2009-04-08 Exelixis, Inc. Methods of using igf1r and abl kinase modulators
BRPI0909375A2 (pt) * 2008-03-28 2015-08-04 Altiris Therapeutics Moduladores de receptores de quimiocinas
CN102046609B (zh) * 2008-03-31 2014-05-14 全药工业株式会社 具有细胞保护效果的嘧啶衍生物及其应用
DK2268635T3 (en) 2008-04-21 2015-09-14 Taigen Biotechnology Co Ltd Heterocyclic Compounds
WO2010046780A2 (en) 2008-10-22 2010-04-29 Institut Pasteur Korea Anti viral compounds
GB201015411D0 (en) 2010-09-15 2010-10-27 Univ Leuven Kath Anti-cancer activity of novel bicyclic heterocycles
BR112014007310A2 (pt) 2011-09-27 2017-04-04 Novartis Ag 3-pirimidin-4-il-oxazolidin-2-onas como inibidores de idh mutante
WO2013155123A1 (en) 2012-04-10 2013-10-17 Georgia State University Research Foundation, Inc. Compositions and methods for treating otitis media and other conditions with inhibitors of cyld
DK2906563T3 (en) 2012-10-10 2018-06-06 Janssen Sciences Ireland Uc PYRROLO [3,2-D] PYRIMIDINE DERIVATIVES FOR TREATING VIRUS INFECTIONS AND OTHER DISEASES
US20150259649A1 (en) * 2012-11-08 2015-09-17 Emory University Cellular compositions used to restore stem cell or progenitor cell function and methods related thereto

Similar Documents

Publication Publication Date Title
JP2017530193A5 (2)
RU2017109355A (ru) Гетероциклические соединения и их применение
PE20141700A1 (es) Compuestos de 2-(2,4,5-anilino sustituido) pirimidina
JP2021512150A5 (2)
CY1118909T1 (el) Αμιδια οξαλικου οξεος ως αναστολεις νεπριλυσινης, φαρμακευτικη συνθεση αυτων και παρασκευη αυτων
JP2016518328A5 (2)
JP2015522650A5 (2)
JP2016516043A5 (2)
JP2016053042A5 (2)
AR086983A1 (es) Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de jak
PE20190395A1 (es) Pirimidin-2-ilamino-1h-pirazoles como inhibidores de lrrk2 para el uso en el tratamiento de trastornos neurodegenerativos
JP2016515560A5 (2)
JP2014506599A5 (2)
JP2017509586A5 (2)
JP2016540803A5 (2)
JP2007524696A5 (2)
RU2013109132A (ru) Химические соединения
JP2015534574A5 (2)
PE20141598A1 (es) Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina
JP2019529419A5 (2)
JP2014503567A5 (2)
AR073551A1 (es) Pirimidinas macrociclicas como inhibidores de proteina cinasa
AR067513A1 (es) Derivados de 1,2-oxazol
JP2016513696A5 (2)
PE20080856A1 (es) Inhibidores de metaloproteasas de matriz